Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Grant or award Senior Vice President, Devices acquired 15,808 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 44,250 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Chief Financial Officer acquired 24,193 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Chief Financial Officer acquired 8,333 shares (grant or award)
  11. 4 Grant or award Director acquired 111,000 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 41,666 shares (grant or award)
  13. 4 Grant or award Director acquired 50,000 shares (grant or award)
  14. 4 Open-market buy President and CEO bought 500 shares at an average $3.03 ($1,513)
  15. 4 Open-market buy President and CEO bought 500 shares at $3.29 ($1,645)
  16. 4 Open-market buy President and CEO bought 500 shares at $3.52 ($1,760)
  17. 4 Open-market buy President and CEO bought 1,000 shares at $3.36 ($3,360)
  18. 4 Open-market buy President and CEO bought 2,750 shares at $0.37 ($1,013)
  19. 4 Open-market buy President and CEO bought 500 shares at $0.39 ($195)
  20. 4 Open-market buy President and CEO bought 108,108 shares at $0.46 ($50,000)

Page 5 of 23 · 442 filings